What Is Cagrilintide?
What Is Cagrilintide?
Cagrilintide is a synthetic analogue of amylin — a hormone naturally released by the pancreas alongside insulin after eating. Amylin plays a role in signaling fullness and regulating how quickly food moves through the digestive tract.
How Does It Work?
By mimicking amylin’s effects in the brain and digestive system, cagrilintide is being studied for its ability to reduce appetite, slow gastric emptying, and complement the metabolic effects of GLP-1 receptor agonists like semaglutide.
Educational Video
Educational Video Coming Soon
We are producing educational videos for every peptide in the Mana Health Peptide Library. This video will be available soon.
Potential Benefits
The following represents areas of active research — not confirmed medical benefits. This is educational information only.
Things To Know
Possible Side Effects
Nausea and injection site reactions have been noted in studies. Used in combination with other agents, effects may be additive. Professional oversight required.
Current Research
Cagrilintide is in active clinical development, with published trials examining its effects alone and in combination with semaglutide (CagriSema) for metabolic health outcomes.
Frequently Asked Questions
Safety profiles for Cagrilintide are still being established. Always consult a qualified healthcare professional before making any health decisions. This information is for educational purposes only.
Explore the related health categories, search our Health Library, or speak with a qualified healthcare professional for personalized guidance.
The Bottom Line
Cagrilintide is an active area of peptide research with growing scientific interest. Like all research peptides, it should be understood in an educational context. Health decisions should always be made with a qualified healthcare professional who understands your individual situation.